Cargando…

Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study

Potts shunt (PS) was suggested as palliation for patients with suprasystemic pulmonary arterial hypertension (PAH) and right ventricular (RV) failure. PS, however, can result in poorly understood mortality. Here, a patient-specific geometrical multiscale model of PAH physiology and PS is developed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pant, Sanjay, Sizarov, Aleksander, Knepper, Angela, Gossard, Gaëtan, Noferi, Alberto, Boudjemline, Younes, Vignon-Clementel, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940869/
https://www.ncbi.nlm.nih.gov/pubmed/35000016
http://dx.doi.org/10.1007/s10237-021-01545-2
_version_ 1784672990650171392
author Pant, Sanjay
Sizarov, Aleksander
Knepper, Angela
Gossard, Gaëtan
Noferi, Alberto
Boudjemline, Younes
Vignon-Clementel, Irene
author_facet Pant, Sanjay
Sizarov, Aleksander
Knepper, Angela
Gossard, Gaëtan
Noferi, Alberto
Boudjemline, Younes
Vignon-Clementel, Irene
author_sort Pant, Sanjay
collection PubMed
description Potts shunt (PS) was suggested as palliation for patients with suprasystemic pulmonary arterial hypertension (PAH) and right ventricular (RV) failure. PS, however, can result in poorly understood mortality. Here, a patient-specific geometrical multiscale model of PAH physiology and PS is developed for a paediatric PAH patient with stent-based PS. In the model, 7.6mm-diameter PS produces near-equalisation of the aortic and PA pressures and [Formula: see text] (oxygenated vs deoxygenated blood flow) ratio of 0.72 associated with a 16% decrease of left ventricular (LV) output and 18% increase of RV output. The flow from LV to aortic arch branches increases by 16%, while LV contribution to the lower body flow decreases by 29%. Total flow in the descending aorta (DAo) increases by 18% due to RV contribution through the PS with flow into the distal PA branches decreasing. PS induces 18% increase of RV work due to its larger stroke volume pumped against lower afterload. Nonetheless, larger RV work does not lead to increased RV end-diastolic volume. Three-dimensional flow assessment demonstrates the PS jet impinging with a high velocity and wall shear stress on the opposite DAo wall with the most of the shunt flow being diverted to the DAo. Increasing the PS diameter from 5mm up to 10mm results in a nearly linear increase in post-operative shunt flow and a nearly linear decrease in shunt pressure-drop. In conclusion, this model reasonably represents patient-specific haemodynamics pre- and post-creation of the PS, providing insights into physiology of this complex condition, and presents a predictive tool that could be useful for clinical decision-making regarding suitability for PS in PAH patients with drug-resistant suprasystemic PAH.
format Online
Article
Text
id pubmed-8940869
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89408692022-04-07 Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study Pant, Sanjay Sizarov, Aleksander Knepper, Angela Gossard, Gaëtan Noferi, Alberto Boudjemline, Younes Vignon-Clementel, Irene Biomech Model Mechanobiol Original Paper Potts shunt (PS) was suggested as palliation for patients with suprasystemic pulmonary arterial hypertension (PAH) and right ventricular (RV) failure. PS, however, can result in poorly understood mortality. Here, a patient-specific geometrical multiscale model of PAH physiology and PS is developed for a paediatric PAH patient with stent-based PS. In the model, 7.6mm-diameter PS produces near-equalisation of the aortic and PA pressures and [Formula: see text] (oxygenated vs deoxygenated blood flow) ratio of 0.72 associated with a 16% decrease of left ventricular (LV) output and 18% increase of RV output. The flow from LV to aortic arch branches increases by 16%, while LV contribution to the lower body flow decreases by 29%. Total flow in the descending aorta (DAo) increases by 18% due to RV contribution through the PS with flow into the distal PA branches decreasing. PS induces 18% increase of RV work due to its larger stroke volume pumped against lower afterload. Nonetheless, larger RV work does not lead to increased RV end-diastolic volume. Three-dimensional flow assessment demonstrates the PS jet impinging with a high velocity and wall shear stress on the opposite DAo wall with the most of the shunt flow being diverted to the DAo. Increasing the PS diameter from 5mm up to 10mm results in a nearly linear increase in post-operative shunt flow and a nearly linear decrease in shunt pressure-drop. In conclusion, this model reasonably represents patient-specific haemodynamics pre- and post-creation of the PS, providing insights into physiology of this complex condition, and presents a predictive tool that could be useful for clinical decision-making regarding suitability for PS in PAH patients with drug-resistant suprasystemic PAH. Springer Berlin Heidelberg 2022-01-09 2022 /pmc/articles/PMC8940869/ /pubmed/35000016 http://dx.doi.org/10.1007/s10237-021-01545-2 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Pant, Sanjay
Sizarov, Aleksander
Knepper, Angela
Gossard, Gaëtan
Noferi, Alberto
Boudjemline, Younes
Vignon-Clementel, Irene
Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
title Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
title_full Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
title_fullStr Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
title_full_unstemmed Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
title_short Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
title_sort multiscale modelling of potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940869/
https://www.ncbi.nlm.nih.gov/pubmed/35000016
http://dx.doi.org/10.1007/s10237-021-01545-2
work_keys_str_mv AT pantsanjay multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy
AT sizarovaleksander multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy
AT knepperangela multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy
AT gossardgaetan multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy
AT noferialberto multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy
AT boudjemlineyounes multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy
AT vignonclementelirene multiscalemodellingofpottsshuntasapotentialpalliativetreatmentforsuprasystemicidiopathicpulmonaryarteryhypertensionapaediatriccasestudy